| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3074718 | F | Antioxidant activity assessed as DPPH radical scavenging activity at 15 ug/ml after 30 min by spectrophotometric analysis | 10 | ALA3046235 | assay format | Scientific Literature | ||
| 2. | ALA3074719 | F | Antimicrobial activity against Candida albicans assessed as growth inhibition by disk diffusion method | Candida albicans | 10 | ALA3046235 | organism-based format | Scientific Literature | |
| 3. | ALA3074720 | F | Antimicrobial activity against Aspergillus niger assessed as growth inhibition by disk diffusion method | Aspergillus niger | 10 | ALA3046235 | organism-based format | Scientific Literature | |
| 4. | ALA3074721 | F | Antimicrobial activity against Escherichia coli isolated from infected patient assessed as growth inhibition by disk diffusion method | Escherichia coli | 10 | ALA3046235 | organism-based format | Scientific Literature | |
| 5. | ALA3074722 | F | Antimicrobial activity against Salmonella enterica subsp. enterica serovar Typhi isolated from infected patient assessed as growth inhibition by disk diffusion method | Salmonella enterica subsp. enterica serovar Typhi | 10 | ALA3046235 | organism-based format | Scientific Literature | |
| 6. | ALA3074723 | F | Antimicrobial activity against Bacillus subtilis isolated from infected patient assessed as growth inhibition by disk diffusion method | Bacillus subtilis | 10 | ALA3046235 | organism-based format | Scientific Literature | |
| 7. | ALA3074724 | F | Antimicrobial activity against Staphylococcus aureus isolated from infected patient assessed as growth inhibition by disk diffusion method | Staphylococcus aureus | 10 | ALA3046235 | organism-based format | Scientific Literature | |
| 8. | ALA3073981 | F | Antimicrobial activity against Candida albicans assessed as diameter of growth inhibition zone at 40 ug/ml by disk diffusion method | Candida albicans | 11 | ALA3046235 | organism-based format | Scientific Literature | |
| 9. | ALA3073982 | F | Antimicrobial activity against Aspergillus niger assessed as diameter of growth inhibition zone at 40 ug/ml by disk diffusion method | Aspergillus niger | 11 | ALA3046235 | organism-based format | Scientific Literature | |
| 10. | ALA3073983 | F | Antimicrobial activity against Escherichia coli isolated from infected patient assessed as diameter of growth inhibition zone at 40 ug/ml by disk diffusion method | Escherichia coli | 11 | ALA3046235 | organism-based format | Scientific Literature | |
| 11. | ALA3073984 | F | Antimicrobial activity against Salmonella enterica subsp. enterica serovar Typhi isolated from infected patient assessed as diameter of growth inhibition zone at 40 ug/ml by disk diffusion method | Salmonella enterica subsp. enterica serovar Typhi | 11 | ALA3046235 | organism-based format | Scientific Literature | |
| 12. | ALA3073985 | F | Antimicrobial activity against Bacillus subtilis isolated from infected patient assessed as diameter of growth inhibition zone at 40 ug/ml by disk diffusion method | Bacillus subtilis | 11 | ALA3046235 | organism-based format | Scientific Literature | |
| 13. | ALA3073986 | F | Growth inhibition of Homo sapiens (human) HepG2 cells at 25 to 100 ug/ml after 48 hr by MTT assay | Homo sapiens | 3 | ALA3046235 | cell-based format | Scientific Literature | |
| 14. | ALA3073987 | F | Antimicrobial activity against Staphylococcus aureus isolated from infected patient assessed as diameter of growth inhibition zone at 40 ug/ml by disk diffusion method | Staphylococcus aureus | 11 | ALA3046235 | organism-based format | Scientific Literature | |
| 15. | ALA3073989 | F | Cytotoxicity against Homo sapiens (human) HepG2 cells assessed as inhibition of cell viability by trypan blue exclusion method | Homo sapiens | 10 | ALA3046235 | cell-based format | Scientific Literature | |
| 16. | ALA3073991 | F | Antiviral activity against Goatpox virus infected African green monkey Vero cells assessed as inhibition of viral replication at MNTC dose incubated for 24 hr measured after 6 days | Goatpox virus | 10 | ALA3046235 | organism-based format | Scientific Literature | |
| 17. | ALA3073992 | F | Antiviral activity against Buffalopox virus virus infected African green monkey Vero cells assessed as inhibition of viral replication at MNTC dose incubated for 24 hr measured after 4 days | Buffalopox virus | 10 | ALA3046235 | organism-based format | Scientific Literature | |
| 18. | ALA3073993 | F | Antiviral activity against Camelpox virus infected African green monkey Vero cells assessed as inhibition of viral replication at MNTC dose incubated for 24 hr measured after 3 days | Camelpox virus | 10 | ALA3046235 | organism-based format | Scientific Literature | |
| 19. | ALA3073994 | F | Antiviral activity against Goatpox virus infected African green monkey Vero cells assessed as reduction of virus titers at MNTC dose incubated for 24 hr measured after 6 days by TCID50 assay | Goatpox virus | 10 | ALA3046235 | organism-based format | Scientific Literature | |
| 20. | ALA3074434 | F | Antiviral activity against Buffalopox virus virus infected African green monkey Vero cells assessed as reduction of virus titers at MNTC dose incubated for 24 hr measured after 4 days by TCID50 assay | Buffalopox virus | 10 | ALA3046235 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!